Cash Flow CK Life Sciences International (Holdings), Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-91.00
68.00
204.00
237.00
117.00
216.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-32.00
69.00
-121.00
-141.00
156.00
-2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
57.00
228.00
229.00
351.00
426.00
231.00
Cash Flow from Investing Activities
-110.00
-81.00
-27.00
-260.00
-465.00
-416.00
Cash Flow from Financing Activities
-32.00
-178.00
-375.00
-145.00
281.00
118.00
Net Cash Inflow / Outflow
-110.00
-27.00
-198.00
-68.00
262.00
-76.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-25.00
4.00
-25.00
-13.00
20.00
-9.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CK Life Sciences International (Holdings), Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-91.63
1242.218025063
-1,333.00
-107.38%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-32.436
240.653239859406
-272.00
-113.48%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
57.611
1226.35257757557
-1,169.00
-95.30%
Cash Flow from Investing Activities
-110.591
-483.925964522314
373.00
77.15%
Cash Flow from Financing Activities
-32.106
-418.731584872261
386.00
92.33%
Net Cash Inflow / Outflow
-110.35
272.54893685833
-382.00
-140.49%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-25.264
-51.1460913226667
26.00
50.60%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -74.77% vs -0.36% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
57.61
228.38
-74.77%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
